Gefiwel Gefitinib Tablets 250 Mg About
Buy Gefiwel Gefitinib Tablets 250 Mg, a highly popular and praiseworthy solution for adults diagnosed with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) harboring EGFR mutations. As an ace antineoplastic agent, Gefiwel delivers sublime efficacy by targeting EGFR, offering a potent and targeted approach to cancer treatment. Being ephemeral in its daily dosing routine-250 mg once orally-this product demands prescription and strict medical supervision. Available in a standard box of 10 white or off-white tablets, Gefiwel stands out as a reliable, precision-driven treatment option crafted in India.
Application Areas and Method: Targeted Precision for NSCLC
Gefiwel Gefitinib Tablets 250 Mg are uniquely formulated for adults suffering from Non-Small Cell Lung Cancer (NSCLC) with EGFR mutations. The application surface is internal, as the medicine is administered orally. The application method involves consuming one tablet (250 mg) once daily, ideally at the same time each day, or as directed by an oncologist. Due to its targeted efficacy, Gefiwel is recognized as an efficient and reliable addition to advanced cancer therapies.
Sample Policy and Market Supply: Proposals and Pricing
For prospective partners and clientele, we offer a modest sample policy, allowing for proposal amounts tailored to demand and scale. Our supply ability ensures consistent dispatching of Gefiwel Gefitinib Tablets across India at the lowest price points, prioritizing both affordability and quality. With a robust distribution network, our main domestic market remains expansive, ensuring rapid access to pharmacies, hospitals, and cancer care centers nationwide.
FAQ's of Gefiwel Gefitinib Tablets 250 Mg:
Q: How should Gefiwel Gefitinib Tablets 250 Mg be taken for optimal results?
A: Gefiwel Gefitinib Tablets should be administered orally, with a recommended dosage of 250 mg once daily, or as directed by your oncologist. Swallow the tablet whole with water, at the same time every day for best results.
Q: What are the primary uses and benefits of Gefiwel Gefitinib Tablets?
A: Gefiwel Gefitinib Tablets are indicated for the treatment of adults with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) that exhibit EGFR mutations. Its targeted mechanism helps slow disease progression and may improve quality of life under medical supervision.
Q: When should this medication be avoided or used with caution?
A: This medication should not be used if you are hypersensitive to Gefitinib or any of its excipients. Always consult your healthcare provider about your full medical history before starting treatment.
Q: What possible side effects may occur while using Gefiwel Gefitinib Tablets?
A: Common side effects include skin rash, diarrhea, dry skin, nausea, vomiting, and loss of appetite. Inform your healthcare provider if any adverse reactions are experienced or persist during therapy.
Q: Where should Gefiwel Gefitinib Tablets be stored to maintain their effectiveness?
A: Store Gefiwel below 30C in a dry place, protected from moisture and light. Always keep the tablets in their original blister strip or box packaging.
Q: What is the process for acquiring Gefiwel Gefitinib Tablets?
A: Gefiwel Gefitinib Tablets are available by prescription only. A licensed oncologist's prescription is required to purchase and begin treatment. Consult your healthcare provider for access and guidance.